Catalent
CTLT
#1508
Rank
โ‚ฌ11.02 B
Marketcap
60,74ย โ‚ฌ
Share price
0.00%
Change (1 day)
32.79%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2023 (TTM): -1,18ย โ‚ฌ

According to Catalent's latest financial reports the company's current EPS (TTM) is -1,23ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 2,17ย โ‚ฌ a decrease over its 2021 EPS that were of 3,13ย โ‚ฌ.

EPS history for Catalent from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,18ย โ‚ฌ-154.22%
20222,17ย โ‚ฌ-30.58%
20213,13ย โ‚ฌ79.67%
20201,74ย โ‚ฌ114.12%
20190,81ย โ‚ฌ-15%
20180,96ย โ‚ฌ75.44%
20170,55ย โ‚ฌ-22.97%
20160,71ย โ‚ฌ-59.56%
20151,75ย โ‚ฌ282.05%
20140,46ย โ‚ฌ-378.2%
2013-0,16ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
0,76ย โ‚ฌ-161.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,72ย โ‚ฌ-41.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-1,35ย โ‚ฌ 9.30%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
6,11ย โ‚ฌ-595.35%๐Ÿ‡บ๐Ÿ‡ธ USA